The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
SMA screening in-service evaluation clinical pathway group holds its first meeting.
The UK National Screening Committee's (UK NSC's) work to improve the newborn screening evidence base features prominently in the England Rare Diseases Action Plan 2024.
Important factors, roles and responsibilities to consider for anyone wanting to conduct research or evaluation into screening.
The UK NSC is consulting on whether to add the quadruple test to the antenatal screening pathway for Edwards' syndrome.
The third UK NSC web-based seminar focused on the potential benefits and limitations of using polygenic scores to calculate the overall chance of developing a disease or condition.
Bursary winners encourage other screening professionals to look into studying master's level health screening module.
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
The UK NSC has held the inaugural meeting of the partnership board which will oversee the development of the in-service evaluation of newborn screening for spinal muscular atrophy in real world NHS services.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes